Bio-Pharmaceuticals Logistics Market: Aarkstore

Bio-pharmaceuticals Logistics Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 2020f

May 26, 2016: A new trending note at Aarkstore on “Bio-pharmaceuticals Logistics Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 2020f” Temperature control, regulatory compliance, security, safety and chain of custody are the key obstacles that can stop the bio-pharmaceutical manufacturers at every turn. As a remedy, the strategic supply chain management will help the manufacturers to overcome these obstacles. Logistics is the key integral part of supply chain management, which deals with procurement, planning and implementation of all the logistics activities in an organization. The effective logistics management will help the pharmaceutical companies to have a constant supply of drugs, devices and equipment from various dealers and distributors in different locations.

The Global Pharmaceutical Market has more than doubled in the past ten years and is expected to reach USD 942 billion in terms of sales volume by the end of 2016. Moreover, patent rights for several leading drugs are set to expire, indicates that large portion of sales will shift from original brand manufacturer to generic manufacturers. Similar to other sectors, the pharmaceutical industry is also undergoing the geographic shift in its production facilities and sales markets. Markets like Asia, Latin America, Middle East, China, etc. are becoming increasingly attractive for these pharmaceutical companies, however, these markets are considered as most challenging in terms of supply chain regulations.

At present, the distribution structure in the European and American markets are heavily inclined towards national warehouses both regionally and centrally. Developing warehouse structures and outsourcing to logistics service providers are the key focus areas for the pharmaceutical manufacturers. Low cost and greater visibility in supply chain are the main...